Prepping for data machination? CDC phases out its 2020 assay of PCR test for SARS CoV-2

Division of Laboratory Systems (DLS)

07/21/2021: Lab Alert: Changes to CDC RT-PCR for SARS-CoV-2 Testing

Audience: Individuals Performing COVID-19 Testing

Level: Laboratory Alert

After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.

Visit the FDA website for a list of authorized COVID-19 diagnostic methods. For a summary of the performance of FDA-authorized molecular methods with an FDA reference panel, visit this page.

In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing.

Opt in to receive updates from the CDC Laboratory Outreach Communication System (LOCS).

Online resources: 

If you have any questions, please contact us at [email protected].

Thank you,

The Laboratory Outreach Communication System

Laboratory Outreach Communication System (LOCS) | Division of Laboratory Systems (DLS)

Center for Surveillance, Epidemiology, and Laboratory Services (CSELS)

Centers for Disease Control and Prevention (CDC)

[email protected]

www.cdc.gov/csels/dls/locs

++++

Reuters: Fact Check-CDC lab update on COVID-19 PCR tests misinterpreted

The CDC is not removing some PCR tests because they failed to differentiate between COVID-19 and Influenza. The agency says it is opting for multiplex assays (that can test for both viruses) to save time and resources.

PB: Reuters’ verdict is misleading. Following WHO plandemic announcement, PCR testing for covid was manipulated so that flu “disappeared” globally. Now, before the Plandemic2.0 due to disarming of immuninty of billions vaxed with the bio-weapon, CDC disinigeniously impresses that multiplexed method should be adopted to enable detection and differentiation of SARS-CoV-2 and influenza viruses:

Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season.

Deaths from the bio-weapon effects will be ascribed to flu and pneumonia complications?

++++

CDC Revokes Emergency Use Authorization To RT-PCR For COVID-19 Testing

Luis TCDCCoronavirusCoronavirus TestCOVID-19false positivesinfluenzaInteresting FactsPCR TestsThe WHO July 25, 2021 3 Minutes

The CDC has announced that they will revoke the emergency use authorization given to RT-PCR for COVID-19 testing.

On 21st July, 2021 the CDC gave out a Laboratory Alert revoking the EUA for RT-PCR tests to detect SARS-COV-2.

“After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Corona-virus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.”

CDC has announced that they will revoke the emergency use authorization given to RT-PCR for COVID-19 testing.

cdc revokes emergency use authorisation to rt pcr for covid 19 testing

On 21st July, 2021 the CDC gave out a Laboratory Alert revoking the EUA for RT-PCR tests to detect SARS-COV-2.

“After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Corona-virus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.”

https://platform.twitter.com/embed/Tweet.html?dnt=true&embedId=twitter-widget-0&features=eyJ0ZndfZXhwZXJpbWVudHNfY29va2llX2V4cGlyYXRpb24iOnsiYnVja2V0IjoxMjA5NjAwLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X2hvcml6b25fdHdlZXRfZW1iZWRfOTU1NSI6eyJidWNrZXQiOiJodGUiLCJ2ZXJzaW9uIjpudWxsfSwidGZ3X3NwYWNlX2NhcmQiOnsiYnVja2V0Ijoib2ZmIiwidmVyc2lvbiI6bnVsbH19&frame=false&hideCard=false&hideThread=false&id=1418978938928369667&lang=en&origin=https%3A%2F%2Fluis46pr.wordpress.com%2F2021%2F07%2F25%2Fcdc-revokes-emergency-use-authorization-to-rt-pcr-for-covid-19-testing%2F&sessionId=903a5f3fabb5081c3b5d5da16442e9df0a4336d9&theme=light&widgetsVersion=fcb1942%3A1632982954711&width=550px

“In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses.”

Numerous courts around the world have determined the use of RT-PCR for detection of SARS-COV-2 as unreliable and downright fraudulent.

Portuguese appeals court has ruled that PCR tests are unreliable and that it is unlawful to quarantine people based solely on a PCR test.

The court stated, the test’s reliability depends on the number of cycles used and the viral load present. Citing Jaafar et al. 2020, the court concludes that:

“if someone is tested by PCR as positive when a threshold of 35 cycles or higher is used (as is the rule in most laboratories in Europe and the US), the probability that said person is infected is less than 3%, and the probability that said result is a false positive is 97%.”

Similarly, the Austrian court has ruled that PCR tests are not suitable for COVID-19 diagnosis and that lockdowns has no legal or scientific basis.

The court pointed out that “a PCR test is not suitable for diagnosis and therefore does not in itself say anything about the disease or infection of a person”.

“However, the Minister of Health uses a completely different, much broader case definition for Covid-19 diagnosis, which cannot be used to justify the prohibition of a meeting.”

Then an Austrian parliamentary member exposed the defectiveness of the government’s COVID-19 tests by demonstrating in the parliament how a glass of Coca-Cola tested positive for COVID-19.

Even the World Health Organization (WHO) itself took a u-turn and changed its PCR test ctiteria cautioning experts not to rely solely on the results of a PCR test to detect the coronavirus.

As GreatGameIndia reported earlier, the standard coronavirus tests threw up a huge number of positive cases daily. These tests are done based on faulty WHO protocols which were designed to include false positives cases as well.

This fact about false positives of PCR Tests was first noted in public by Dr. Beda M. Stadler, a Swiss biologist, emeritus professor, and former director of the Institute of Immunology at the University of Bern.

So if we do a PCR corona test on an immune person, it is not a virus that is detected, but a small shattered part of the viral genome. The test comes back positive for as long as there are tiny shattered parts of the virus left.

Correct: Even if the infectious viruses are long dead, a corona test can come back positive, because the PCR method multiplies even a tiny fraction of the viral genetic material enough [to be detected].

Earlier, the WHO’s testing protocol was even questioned by Finland’s national health authority. WHO had called on countries to test as many patients as possible for coronavirus.

Finland ran out of testing capacity and began limiting coronavirus tests to the most vulnerable groups and healthcare personnel only. Finland’s national health authority said that testing people with mild symptoms would be a waste of healthcare resources.

In a startling disclosure, Finland’s head of health security, Mika Salminen dismissed WHO advisory saying the WHO doesn’t understand pandemics and that their Coronavirus testing protocol is illogical and doesn’t work.

Source: GreatGameIndia.com

Related

Does the Virus Exist? The SARS-CoV-2 Has Not Been Isolated? “Biggest Fraud in Medical History”August 10, 2021In “Big Pharma”

COVID-19 Variant FRAUD Exposed: Why They Won’t Tell You Which Variant You Are Infected WithSeptember 13, 2021In “Children Health”

Bombshell HHS Documents: CDC Has Never Isolated Any ‘Covid-19 Virus’August 9, 2021In “CDC”

Published by Luis T, Puerto Rican in Memphis View all posts by Luis T

By piotrbein

https://piotrbein.net/about-me-o-mnie/